LT2710114T - Gamyba aukšto grynumo iš keleto subvienetų sudarytų baltymų, tokių kaip antikūnai, transformuotuose mikroorganizmuose, tokiuose kaip pichia pastoris - Google Patents

Gamyba aukšto grynumo iš keleto subvienetų sudarytų baltymų, tokių kaip antikūnai, transformuotuose mikroorganizmuose, tokiuose kaip pichia pastoris

Info

Publication number
LT2710114T
LT2710114T LTEPPCT/US2012/036953T LT12036953T LT2710114T LT 2710114 T LT2710114 T LT 2710114T LT 12036953 T LT12036953 T LT 12036953T LT 2710114 T LT2710114 T LT 2710114T
Authority
LT
Lithuania
Prior art keywords
conformed
organisms
manufacture
pichia pastoris
multiple substances
Prior art date
Application number
LTEPPCT/US2012/036953T
Other languages
English (en)
Lithuanian (lt)
Inventor
Patricia Mcneill
Nicole Janson
Gary LESNICKI
Pei Qi
John Latham
Leon Garcia-Martinez
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of LT2710114T publication Critical patent/LT2710114T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LTEPPCT/US2012/036953T 2011-05-20 2012-05-08 Gamyba aukšto grynumo iš keleto subvienetų sudarytų baltymų, tokių kaip antikūnai, transformuotuose mikroorganizmuose, tokiuose kaip pichia pastoris LT2710114T (lt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161488660P 2011-05-20 2011-05-20
US201161496873P 2011-06-14 2011-06-14
US201161496860P 2011-06-14 2011-06-14
US201161525307P 2011-08-19 2011-08-19
PCT/US2012/036953 WO2012161956A2 (en) 2011-05-20 2012-05-08 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris

Publications (1)

Publication Number Publication Date
LT2710114T true LT2710114T (lt) 2021-12-10

Family

ID=47217961

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2012/036953T LT2710114T (lt) 2011-05-20 2012-05-08 Gamyba aukšto grynumo iš keleto subvienetų sudarytų baltymų, tokių kaip antikūnai, transformuotuose mikroorganizmuose, tokiuose kaip pichia pastoris

Country Status (22)

Country Link
EP (1) EP2710114B1 (enExample)
JP (2) JP6193220B2 (enExample)
KR (1) KR101981662B1 (enExample)
CN (2) CN110408644A (enExample)
CA (1) CA2837000C (enExample)
CY (1) CY1124796T1 (enExample)
DK (1) DK2710114T3 (enExample)
EA (1) EA028913B9 (enExample)
ES (1) ES2899381T3 (enExample)
HR (1) HRP20211873T1 (enExample)
HU (1) HUE060418T2 (enExample)
IL (1) IL229430B (enExample)
LT (1) LT2710114T (enExample)
MX (2) MX368546B (enExample)
PL (1) PL2710114T3 (enExample)
PT (1) PT2710114T (enExample)
RS (1) RS62628B1 (enExample)
SG (1) SG194937A1 (enExample)
SI (1) SI2710114T1 (enExample)
SM (1) SMT202100677T1 (enExample)
WO (1) WO2012161956A2 (enExample)
ZA (1) ZA201308639B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX378344B (es) * 2014-03-21 2025-03-10 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos.
TWI734775B (zh) 2016-04-26 2021-08-01 美商美國泰福生技股份有限公司 細胞培養基
SMT202600087T1 (it) 2016-09-23 2026-03-09 Teva Pharmaceuticals Int Gmbh Trattamento dell’emicrania refrattaria
GB201803832D0 (en) * 2018-03-09 2018-04-25 Syndermix Ag Methods and compositions for lectin production
CN108913732B (zh) * 2018-07-31 2022-02-08 华东理工大学 一种莫纳可林j异源生产的方法及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
AU6445894A (en) 1993-03-19 1994-10-11 Duke University Method of treatment of tumors with an antibody binding to tenascin
AU3272695A (en) 1994-08-12 1996-03-07 Immunomedics Inc. Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US6653104B2 (en) 1996-10-17 2003-11-25 Immunomedics, Inc. Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
US6730499B1 (en) 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
WO2000056903A2 (en) * 1999-03-22 2000-09-28 Zymogenetics, Inc. IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA)
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
PL204737B1 (pl) * 2000-12-13 2010-02-26 Unilever Nv Sposób wytwarzania heterologicznego białka przez grzyby
DK1678314T3 (da) 2003-10-22 2012-12-03 Keck Graduate Inst Fremgangsmåde til syntetisering af heteromultimere polypeptider i gær ved anvendelse af en haploid parringsstrategi
WO2008063302A2 (en) * 2006-10-10 2008-05-29 Keck Graduate Institute Novel p. pastoris pastoris promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy
NZ601583A (en) 2007-05-21 2013-08-30 Bristol Myers Squibb Co Novel rabbit antibody humanization methods and humanized rabbit antibodies
DK2164514T3 (en) 2007-05-21 2017-02-27 Alderbio Holdings Llc Antibodies to IL-6 and its use
US9783601B2 (en) 2010-12-01 2017-10-10 Alderbio Holdings Llc Methods of preventing inflammation and treating pain using anti-NGF compositions

Also Published As

Publication number Publication date
MX368546B (es) 2019-10-07
CY1124796T1 (el) 2022-11-25
MX2013013532A (es) 2015-08-20
RS62628B1 (sr) 2021-12-31
IL229430A0 (en) 2014-01-30
ES2899381T3 (es) 2022-03-11
WO2012161956A9 (en) 2013-09-06
JP2018007656A (ja) 2018-01-18
IL229430B (en) 2020-07-30
WO2012161956A2 (en) 2012-11-29
HUE060418T2 (hu) 2023-02-28
JP6491696B2 (ja) 2019-03-27
EA028913B9 (ru) 2018-03-30
SMT202100677T1 (it) 2022-01-10
KR101981662B1 (ko) 2019-05-23
PT2710114T (pt) 2021-12-09
EA201301294A1 (ru) 2014-05-30
CN103827290A (zh) 2014-05-28
CN110408644A (zh) 2019-11-05
DK2710114T3 (da) 2021-12-06
HRP20211873T1 (hr) 2022-03-04
MX2019012022A (es) 2019-11-18
EA028913B1 (ru) 2018-01-31
EP2710114B1 (en) 2021-11-03
EP2710114A2 (en) 2014-03-26
BR112013029902A2 (pt) 2016-12-20
CA2837000A1 (en) 2012-11-29
JP6193220B2 (ja) 2017-09-06
CA2837000C (en) 2021-09-14
PL2710114T3 (pl) 2022-01-17
NZ718187A (en) 2017-10-27
JP2014517698A (ja) 2014-07-24
KR20140033445A (ko) 2014-03-18
SI2710114T1 (sl) 2022-01-31
ZA201308639B (en) 2026-05-27
EP2710114A4 (en) 2014-11-19
SG194937A1 (en) 2013-12-30
WO2012161956A3 (en) 2013-01-17
NZ618635A (en) 2016-09-30

Similar Documents

Publication Publication Date Title
BR112012027001A2 (pt) produção de proteínas heteromultiméricas
PL3590949T3 (pl) Kwasy rybonukleinowe zawierające n1-metylo-pseudouracyle i ich zastosowania
DK3235907T3 (da) Metabolisk modificerede organismer til produktion af bioprodukter med merværdi
GB201101999D0 (en) Improvements in or relating to methods of manufacture
IL228438A0 (en) New methods for protein purification
BRDI7105042S (pt) " configuração aplicada em jarra "
DK2598514T3 (da) Proteinoprensning
EP2535065A4 (en) DIALYSIS MACHINE
SG10201606218WA (en) Purified Proteins
EP2771381A4 (en) Bacterial production of methyl ketones
EP2548997A4 (en) Electrolyzer
ZA201305485B (en) Plant protein hydrolysates
IL229430B (en) High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
BRPI1005147A2 (pt) processo de preparação de sais de rosuvastatina
FI20100248A0 (fi) Menetelmä proteiinien tuottamiseksi
EP2688564A4 (en) CALCIUM ADDITIVE
EP2657957A4 (en) EVAPORATOR
GB201101794D0 (en) Protein production
BR112012024093A2 (pt) processo de preparação contínuo
ES1073234Y (es) Celosia
HK1196393A (en) High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
AU2010142V (en) Maxima Mangifera indica
HUP1100282A2 (en) Protein factor
ITBS20110046U1 (it) Scaldavivande
FIU20110141U0 (fi) Muovinen tai komposiittirakenteinen säiliö